Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2025-12-25 @ 5:11 AM
NCT ID:
NCT05708027
Eligibility Criteria:
Inclusion Criteria:
* persistent or long-lasting persistent form of atrial fibrillation;
* age over 18 years;
* failure of conservative therapy with the use of Class I and III antiarrhythmic drugs (Vaughan Williams classification);
* absence of marked structural pathology of the heart, requiring surgical treatment.
Exclusion Criteria:
* secondary atrial fibrillation due to reversible cause (pericarditis, hyperthyroidism, TELA, pneumonia, hypokalemia, etc.);
* surgical interventions on thoracic or mediastinal organs;
* age less than 18 years;
* presence of indications for open heart surgery under conditions of artificial circulation;
* heart failure with ejection fraction less than 30%;
* acute cerebral circulation disorder less than 3 months old;
* acute myocardial infarction or coronary stenting less than 3 months old;
* active systemic infection;
* left atrial appendage thrombosis detected one day before surgery;
* hemodynamically significant atherosclerotic lesion of coronary arteries and myocardial ischemia at the time of indications for surgery (confirmed by functional tests and coronarography);
* presence of contraindications for direct and indirect anticoagulants;
* presence of concomitant diseases of other organs and systems, which can lead to death within the first 2 years after the operation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05708027
Study Brief:
Protocol Section:
NCT05708027